Opportunity
SAM #HT941027N0008
Sole-source purchase of a Shoulder Innovations System for emergency reverse shoulder arthroplasty
Buyer
Department of Defense
Posted
October 27, 2026
Respond By
October 28, 2026
Identifier
HT941027N0008
NAICS
339112, 423450
The Defense Health Agency Contracting Activity plans an urgent sole-source purchase of a shoulder implant system for Madigan Army Medical Center. - Buyer: Defense Health Agency Contracting Activity, Healthcare Contracting Division – San Diego. - Requirement: One Shoulder Innovations System for emergency reverse shoulder arthroplasty for a patient with a proximal humerus fracture, a small glenoid, and moderate superior inclination. The system is described as having a lower-profile glenoid baseplate and surgical planning capabilities to help address the deformity. - Sole-source vendor: Source Medical Systems, Inc. The notice identifies this company as the sole source but does not identify the system’s OEM; the vendor should not be assumed to be the manufacturer. - Procurement approach: Firm-fixed-price purchase order; the notice cites Other Than Full and Open Competition and says it does not expect quotes from two or more small businesses. - Delivery: Required by October 27, 2026. No contract duration or option period is provided. - Capability statements: Vendors challenging the sole-source basis may submit capability statements by 10:00 a.m. PDT on October 28, 2026. - Unspecified details: No quantity, part number, or estimated contract value is stated.
Description
The Department of Orthopedic Surgery requests to procure the shoulder innovation system in order to treat an emergency procedure. This patient requires this implant system due to the patients anatomy and injury pattern. The patient has a proximal humerus fracture and is indicated for reverse shoulder arthroplasty. The patient has a very small glenoid as well as moderate superior inclination. This system offers a lower profile glenoid baseplate as well as providing a mechanism for surgical planning and correction of the deformity. Because these are proprietary components distributed exclusively by the OEM, there is no reasonable expectation of receiving quotes from two (2) or more small businesses. Accordingly, the proposed acquisition strategy is to execute this procurement on a sole-source basis under the authority of Other Than Full and Open Competition.